Literature DB >> 24129695

Relevance of tricuspid annular peak systolic velocity (s') to detect systolic right-ventricular impairment after anthracycline cancer treatment in childhood.

Gunther Gores1, William Ravekes, Martin Koestenberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24129695     DOI： 10.1007/s00246-013-0812-3

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


× No keyword cloud information.
  4 in total

1.  Reference values of tricuspid annular peak systolic velocity in healthy pediatric patients, calculation of z score, and comparison to tricuspid annular plane systolic excursion.

Authors:  Martin Koestenberger; Bert Nagel; William Ravekes; Alexander Avian; Bernd Heinzl; Gerhard Cvirn; Peter Fritsch; Andrea Fandl; Thomas Rehak; Andreas Gamillscheg
Journal:  Am J Cardiol       Date:  2011-09-23       Impact factor: 2.778

2.  Assessment of early-onset chronic progressive anthracycline cardiotoxicity in children: different response patterns of right and left ventricles.

Authors:  Abdullah Kocabaş; Fırat Kardelen; Halil Ertuğ; Bilge Aldemir-Kocabaş; Özgür Tosun; Akif Yeşilipek; Volkan Hazar; Gayaz Akçurin
Journal:  Pediatr Cardiol       Date:  2013-07-03       Impact factor: 1.655

3.  Growth-differentiation factor-15 and tissue doppler ımaging in detection of asymptomatic anthracycline cardiomyopathy in childhood cancer survivors.

Authors:  Derya Arslan; Tugba Cihan; Dogan Kose; Husamettin Vatansev; Derya Cimen; Yavuz Koksal; Bulent Oran; Fikret Akyurek
Journal:  Clin Biochem       Date:  2013-07-11       Impact factor: 3.281

4.  Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer.

Authors:  Kaisa Ylänen; Tuija Poutanen; Päivi Savikurki-Heikkilä; Irina Rinta-Kiikka; Anneli Eerola; Kim Vettenranta
Journal:  J Am Coll Cardiol       Date:  2013-04-09       Impact factor: 24.094
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.